Presentation TCT 2024 TCT 700: Drug-Loss at Arterial Bends Can Dominate Off-Target Drug Delivery by Paclitaxel-Coated Balloons Presenter: Linnea Tscheuschner October 29, 2024
Presentation TCT 2024 Drug Delivery Technologies for the SFA: Where are We Now After the Paclitaxel Scare? Presenter: Sahil Parikh October 28, 2024
Presentation TCT 2023 TCT 431: Comparison of the efficacy of sirolimus and paclitaxel-eluting balloon catheters in the Treatment of coronary In-Stent restenosis: the TIS-2 study. Presenter: Leos Pleva October 24, 2023
Presentation TCT 2023 TCT 279: Treatment of In-Stent Restenosis With Sirolimus- Versus Paclitaxel-Coated Balloons Presenter: Matthias Bossard October 24, 2023
Presentation TCT 2021 Have We Gotten to the Final Word on Paclitaxel Safety? Presenter: Eric Secemsky November 06, 2021
Presentation TCT 2020 Where Are We With the Data on Paclitaxel? Presenter: Eric Secemsky October 18, 2020
Presentation TCT 2020 ILLUMENATE: Four-Year Results With a Low-Dose Paclitaxel Drug-Coated Balloon in De Novo And Restenotic Femoropopliteal Lesions Presenter: Andrew Holden October 18, 2020
Presentation TCT 2020 TCT 370: A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease Presenter: Brian Forrestal October 14, 2020
Presentation TCT 2019 Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA? Presenter: Thomas Zeller September 27, 2019
Presentation TCT 2019 Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoro-Popliteal Occlusive Disease: 3-Year Clinical and Ambulatory Outcome Presenter: Piotr Buszman September 27, 2019
Presentation TCT 2019 Emerging Safety Signals and FDA’s Medical Device Safety Action Plan: Responses to the Late Mortality Signal Presenter: Rebecca Ward September 26, 2019
Presentation TCT 2019 Potential Study Designs to Address the Mortality Safety Signal Presenter: Laura Mauri September 26, 2019
Presentation TCT 2019 Informed Consent and Impact on Clinical Practice: A Clinician’s Perspective and a Pathway Forward Presenter: Sahil Parikh September 26, 2019
Presentation TCT 2019 Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward Presenter: Ian Meredith AM September 26, 2019
Presentation TCT 2019 Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible? Presenter: Elazer Edelman September 26, 2019
Presentation TCT 2019 Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data Presenter: Krishna Rocha-Singh September 26, 2019
Presentation TCT 2019 New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated) Presenter: Konstantinos Katsanos September 26, 2019
Presentation TCT 2019 1-Year Late Lumen Loss With a Polymer-Coated Paclitaxel-Eluting Stent and a Polymer-Free Paclitaxel-Coated Stent for Femoropopliteal Disease: Study Results Presenter: Daizo Kawasaki September 26, 2019
Presentation TCT 2019 Mortality Risk Following Application of Paclitaxel-Coated Devices in Femoropopliteal Lesion: Results From the CAROOT Study Presenter: Yoshimitsu Soga September 26, 2019
Presentation TCT 2019 TCT 62: A polymer-free paclitaxel eluting stent (Zilver® PTX®) versus a bare metal stent (Misago®) for de novo femoropopliteal lesions (BATTLE): a randomised trial Presenter: Yann Gouëffic September 25, 2019